AR008838A1 - Nuevo tratamiento. - Google Patents
Nuevo tratamiento.Info
- Publication number
- AR008838A1 AR008838A1 ARP970104238A ARP970104238A AR008838A1 AR 008838 A1 AR008838 A1 AR 008838A1 AR P970104238 A ARP970104238 A AR P970104238A AR P970104238 A ARP970104238 A AR P970104238A AR 008838 A1 AR008838 A1 AR 008838A1
- Authority
- AR
- Argentina
- Prior art keywords
- pain
- neuralgia
- diseases
- treatment
- new treatment
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title abstract 2
- 208000004296 neuralgia Diseases 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 206010003591 Ataxia Diseases 0.000 abstract 1
- 206010058019 Cancer Pain Diseases 0.000 abstract 1
- 206010008748 Chorea Diseases 0.000 abstract 1
- 208000017164 Chronobiology disease Diseases 0.000 abstract 1
- 201000004311 Gilles de la Tourette syndrome Diseases 0.000 abstract 1
- 208000007101 Muscle Cramp Diseases 0.000 abstract 1
- 208000002740 Muscle Rigidity Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract 1
- 208000005392 Spasm Diseases 0.000 abstract 1
- 208000009205 Tinnitus Diseases 0.000 abstract 1
- 208000000323 Tourette Syndrome Diseases 0.000 abstract 1
- 208000016620 Tourette disease Diseases 0.000 abstract 1
- 208000030886 Traumatic Brain injury Diseases 0.000 abstract 1
- 150000001562 benzopyrans Chemical class 0.000 abstract 1
- 208000012601 choreatic disease Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000019622 heart disease Diseases 0.000 abstract 1
- 206010022437 insomnia Diseases 0.000 abstract 1
- 210000002161 motor neuron Anatomy 0.000 abstract 1
- 201000003631 narcolepsy Diseases 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 230000007971 neurological deficit Effects 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 208000019116 sleep disease Diseases 0.000 abstract 1
- 231100000886 tinnitus Toxicity 0.000 abstract 1
- 230000009529 traumatic brain injury Effects 0.000 abstract 1
- 206010044652 trigeminal neuralgia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
Derivados y Análogos de benzopirano se describen como utiles para el tratamiento y/o la profilaxis de enfermedades degenerativas tales como corea deHuntingdon, esquizofrenia, déficit neurologicos asociados con el SIDA, trastornos delsueno (incluídos trastornos del ritmo circadiano, insomnio ynarcolepsia), tics (por ejemplo síndrome de Giles de la Tourette), lesion traumática del cerebro, zumbido, neuralgia, especialmente neuralgia trigémina,dolor neuropático, dolordental, dolor de cancer, actividad nuronal inapropiada que resulta en una neurodistesia en enfermedades tales como diabetes, EM, y laenfermedad de la neurona motora, ataxias, rigidez muscular (espasmos) y disfuncion de la uniontémporo-mandibular.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9619492.3A GB9619492D0 (en) | 1996-09-18 | 1996-09-18 | Novel treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR008838A1 true AR008838A1 (es) | 2000-02-23 |
Family
ID=10800127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970104238A AR008838A1 (es) | 1996-09-18 | 1997-09-16 | Nuevo tratamiento. |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0939630B1 (es) |
| JP (1) | JP2001500520A (es) |
| KR (1) | KR20000036184A (es) |
| CN (1) | CN1230885A (es) |
| AP (1) | AP9901473A0 (es) |
| AR (1) | AR008838A1 (es) |
| AT (1) | ATE270102T1 (es) |
| AU (1) | AU730465B2 (es) |
| BG (1) | BG103252A (es) |
| BR (1) | BR9712030A (es) |
| CA (1) | CA2266681A1 (es) |
| DE (1) | DE69729735T2 (es) |
| DZ (1) | DZ2311A1 (es) |
| EA (1) | EA199900306A1 (es) |
| ES (1) | ES2223075T3 (es) |
| GB (1) | GB9619492D0 (es) |
| HU (1) | HUP9904638A3 (es) |
| ID (2) | ID23175A (es) |
| IL (1) | IL128786A0 (es) |
| MA (1) | MA24321A1 (es) |
| NO (1) | NO991292L (es) |
| NZ (1) | NZ334271A (es) |
| OA (1) | OA10998A (es) |
| PE (1) | PE109898A1 (es) |
| PL (1) | PL332313A1 (es) |
| SK (1) | SK35199A3 (es) |
| TR (1) | TR199900527T2 (es) |
| UY (1) | UY24717A1 (es) |
| WO (1) | WO1998011890A1 (es) |
| ZA (1) | ZA978359B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119214B2 (en) * | 2004-04-13 | 2006-10-10 | Cephalon France | Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| CA2726874A1 (en) * | 2008-06-05 | 2009-12-10 | Minster Research Limited | Novel treatments |
| EP2307004A1 (en) * | 2008-06-05 | 2011-04-13 | Minster Research Limited | Novel treatments |
| NZ598942A (en) | 2009-07-27 | 2014-02-28 | Gilead Sciences Inc | Fused heterocyclic compounds as ion channel modulators |
| CN102970991A (zh) * | 2009-12-03 | 2013-03-13 | 普罗克西梅根有限公司 | 异常性疼痛和痛觉增敏的治疗 |
| CN102770134A (zh) * | 2009-12-03 | 2012-11-07 | 普罗克西梅根有限公司 | 传染性失调的治疗 |
| CN103096977B (zh) | 2010-07-02 | 2017-02-15 | 吉利德科学公司 | 作为离子通道调节剂的稠杂环化合物 |
| TWI577670B (zh) | 2011-05-10 | 2017-04-11 | 基利科學股份有限公司 | 充當離子通道調節劑之稠合雜環化合物 |
| NO3175985T3 (es) | 2011-07-01 | 2018-04-28 | ||
| TWI622583B (zh) | 2011-07-01 | 2018-05-01 | 基利科學股份有限公司 | 作為離子通道調節劑之稠合雜環化合物 |
| CN106397317B (zh) * | 2016-09-26 | 2019-03-22 | 天津师范大学 | 1,2,3,4-四氢喹啉化合物及其合成方法与应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9112721D0 (en) * | 1991-06-13 | 1991-07-31 | Smithkline Beecham Plc | Novel treatment |
| US5510375A (en) * | 1993-11-19 | 1996-04-23 | Warner-Lambert Company | Coumarin derivatives as protease inhibitors and antiviral agents |
| GB9411635D0 (en) * | 1994-06-10 | 1994-08-03 | Smithkline Beecham Plc | Novel treatment |
| CN1234702C (zh) * | 1994-06-10 | 2006-01-04 | 史密丝克莱恩比彻姆有限公司 | 苯并吡喃类化合物和包含它们的药物组合物 |
-
1996
- 1996-09-18 GB GBGB9619492.3A patent/GB9619492D0/en active Pending
-
1997
- 1997-09-15 BR BR9712030A patent/BR9712030A/pt not_active IP Right Cessation
- 1997-09-15 CN CN97197979A patent/CN1230885A/zh active Pending
- 1997-09-15 KR KR1019997002238A patent/KR20000036184A/ko not_active Withdrawn
- 1997-09-15 PL PL97332313A patent/PL332313A1/xx unknown
- 1997-09-15 NZ NZ334271A patent/NZ334271A/en unknown
- 1997-09-15 EP EP97909300A patent/EP0939630B1/en not_active Expired - Lifetime
- 1997-09-15 HU HU9904638A patent/HUP9904638A3/hu unknown
- 1997-09-15 AT AT97909300T patent/ATE270102T1/de not_active IP Right Cessation
- 1997-09-15 JP JP10514309A patent/JP2001500520A/ja not_active Ceased
- 1997-09-15 TR TR1999/00527T patent/TR199900527T2/xx unknown
- 1997-09-15 DE DE69729735T patent/DE69729735T2/de not_active Expired - Fee Related
- 1997-09-15 WO PCT/EP1997/005168 patent/WO1998011890A1/en not_active Ceased
- 1997-09-15 CA CA002266681A patent/CA2266681A1/en not_active Abandoned
- 1997-09-15 EA EA199900306A patent/EA199900306A1/ru unknown
- 1997-09-15 SK SK351-99A patent/SK35199A3/sk unknown
- 1997-09-15 AP APAP/P/1999/001473A patent/AP9901473A0/en unknown
- 1997-09-15 ID IDW990097A patent/ID23175A/id unknown
- 1997-09-15 ES ES97909300T patent/ES2223075T3/es not_active Expired - Lifetime
- 1997-09-15 IL IL12878697A patent/IL128786A0/xx unknown
- 1997-09-15 AU AU47047/97A patent/AU730465B2/en not_active Ceased
- 1997-09-16 ID IDP973201A patent/ID19542A/id unknown
- 1997-09-16 AR ARP970104238A patent/AR008838A1/es not_active Application Discontinuation
- 1997-09-16 UY UY24717A patent/UY24717A1/es not_active Application Discontinuation
- 1997-09-16 MA MA24799A patent/MA24321A1/fr unknown
- 1997-09-17 ZA ZA978359A patent/ZA978359B/xx unknown
- 1997-09-17 DZ DZ970161A patent/DZ2311A1/xx active
- 1997-09-18 PE PE1997000831A patent/PE109898A1/es not_active Application Discontinuation
-
1999
- 1999-03-15 BG BG103252A patent/BG103252A/xx unknown
- 1999-03-17 NO NO991292A patent/NO991292L/no not_active Application Discontinuation
- 1999-03-18 OA OA9900060A patent/OA10998A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DZ2311A1 (fr) | 2002-12-28 |
| NZ334271A (en) | 2001-03-30 |
| ZA978359B (en) | 1999-03-17 |
| CA2266681A1 (en) | 1998-03-26 |
| MA24321A1 (fr) | 1998-04-01 |
| ID23175A (id) | 2000-03-23 |
| AP9901473A0 (en) | 1999-03-31 |
| KR20000036184A (ko) | 2000-06-26 |
| PL332313A1 (en) | 1999-08-30 |
| PE109898A1 (es) | 1999-03-21 |
| DE69729735T2 (de) | 2005-07-14 |
| UY24717A1 (es) | 2001-08-27 |
| JP2001500520A (ja) | 2001-01-16 |
| BR9712030A (pt) | 1999-08-24 |
| HUP9904638A3 (en) | 2001-08-28 |
| TR199900527T2 (xx) | 1999-06-21 |
| AU4704797A (en) | 1998-04-14 |
| EA199900306A1 (ru) | 1999-08-26 |
| EP0939630A1 (en) | 1999-09-08 |
| ES2223075T3 (es) | 2005-02-16 |
| AU730465B2 (en) | 2001-03-08 |
| CN1230885A (zh) | 1999-10-06 |
| GB9619492D0 (en) | 1996-10-30 |
| BG103252A (en) | 1999-09-30 |
| OA10998A (en) | 2003-03-04 |
| IL128786A0 (en) | 2000-01-31 |
| NO991292D0 (no) | 1999-03-17 |
| SK35199A3 (en) | 2000-07-11 |
| WO1998011890A1 (en) | 1998-03-26 |
| HUP9904638A2 (hu) | 2001-05-28 |
| EP0939630B1 (en) | 2004-06-30 |
| ATE270102T1 (de) | 2004-07-15 |
| DE69729735D1 (de) | 2004-08-05 |
| NO991292L (no) | 1999-03-17 |
| ID19542A (id) | 1998-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR008838A1 (es) | Nuevo tratamiento. | |
| DE60216139D1 (de) | Arylharnstoff-verbindungen in kombination mit anderen zytostatisch oder zytotoxisch wirksamen stoffen zur behandlungen menschlicher krebserkrankungen | |
| IL225192A (en) | Combinations of dextromethorphan and quinidine for the preparation of mental illness, neuropathic pain or brain injury | |
| ATE214903T1 (de) | Verwendung von perfluorkohlenwasserstoffen zur herstellung von potenzierungsmitteln für die ultraschallvermittelte hyperthermiebehandlung von biologischen geweben | |
| WO2004060146A3 (en) | Method of treatment for central nervous system injury | |
| IL191068A0 (en) | Apparatus for treating neurological disorders by means of chronic adaptive brain stimulation as a function of local biopotentials | |
| ES2082887T3 (es) | Flupirtina en combinacion con antiparkinsonianos para combatir espasmos musculares. | |
| CY1107054T1 (el) | Ενωσεις διτοσυλικου αλατος κιναζολινης | |
| DE69827513D1 (de) | Anordnung zur behandlung von neurodegenerativen störungen mittels infusion von nervenwachstumsfaktoren in das gehirn | |
| WO2007061750A3 (en) | Adipose tissue derived stromal cells for the treatment of neurological disorders | |
| ZA95884B (en) | Chloropyrimidine intermediates | |
| DE60142236D1 (de) | Substituierte 5-alkinyl-pyrimidine mit neurotropher wirkung | |
| EP0348353A3 (en) | The use of physiologically active substances for the manufacture of drugs for cerebral and neuronal diseases | |
| EP0533585B1 (en) | Apparatus for regulating and improving the status of development and survival of living organisms | |
| GT200000203A (es) | Compuestos, composiciones y metodos para estimular el crecimiento y elongacion de neuronas. | |
| WO2002066469A3 (en) | Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands | |
| ES2150021T3 (es) | Derivados de acidos piridin- y pirazin-dicarboxilicos como reguladores de la proliferacion celular. | |
| US20210186803A1 (en) | Vibratory infrared oligodynamic apparatus and musculoskeletal pain treatment method using same | |
| ES2134709A1 (es) | Utilizacion de los derivados de 1-(4-(4-aril (0 heteroaril)-1-piperazinil)-butil)-1h-azol para la preparacion de un medicamento destinado al tratamiento de los transtornos obsesivo-compulsivos, de la apnea del sueño, de las disfunciones sexuales, de la emesis y del mareo en los m | |
| WO2000061231A3 (en) | Medical use | |
| WO1999056666A8 (en) | The treatment of sexual dysfunction in certain patient groups | |
| ECSP972256A (es) | Nuevo tratamiento y/o profilaxis de enfermedades degenerativas | |
| IL164779A0 (en) | Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other oculat disorders | |
| RU94006635A (ru) | Способ коррекции функциональных состояний | |
| AU2003227593A1 (en) | New analogs of nitrobenzylthioinosine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |